Medical and Pharmaceutical

The state's national average is a mere 26%

The rebrand is bringing Halma Group companies Perma Pure and Maxtec together

The authorization could help facilitate significant revenue growth

The capital injection follows financial difficulties

BriaCell originally licensed the technology from the University of Maryland

She held a book signing for 'One Scan Saved My Life' this week

More than 300 people participated in the 13th annual fundraiser

The company was recognized for its multi-cancer detection test

Insilico has developed at least 28 drug candidates using generative AI tools

Enliven Therapeutics is a clinical-stage biotech company focused on developing targeted cancer drugs

'Healthy Workforce, Productive Community' will extend for 3 years

Shares rose by 73% during the session with no immediate catalyst

It can provide results within 10 minutes

Cancer remains a leading cause of death across Asia, driving demand for early screening tools

It aims to identify an optimal dosing regimen for patients that minimizes anxiety

Shares dropped by 88% on Friday the 13th, leaving investors shook

The Median system reported 93.3 per cent sensitivity and 92.4 per cent specificity when identifying malignant lung nodules

'Aletta' uses AI and 3D ultrasound guidance for proper placement of a robotic needle

MiniMed makes insulin delivery and glucose monitoring devices

The company is planning an NDA submission for its flagship drug as a Babesiosis treatment

The test analyzes sputum samples using flow cytometry to identify cancer-related cellular changes

Investors are optimistic about the therapeutic's potential as a superior alternative for CDI treatment

Its MedTech Commercialisation Advancement Program has been expediting the tool's development

Researchers think combining both drugs could create stronger and longer-lasting tumor responses

'Radiological computer-assisted diagnostic software for lesions suspicious of cancer' is what the FDA calls it

It uses nanosensors and AI algorithms to detect volatile organic compounds linked to the disease

Shares surged by 16% after the deal was announced

The research focused on hematopoietic stem cells, often called HSCs

The drug being examined, stenoparib, is also showing promise in ovarian cancer treatment

Median secured FDA 510(k) approval for eyonis LCS on Feb. 9

The slide comes in tandem with financial results that beat expectations

The FDA grants Breakthrough Device status to a limited group of technologies

Cell therapies have gained ground in recent years as doctors turn patients’ immune systems into “living drugs.”

The group combined DNA nanostructures, quantum dots and CRISPR gene-editing tools with a light-based technique called second harmonic generation

Northstar Select already identifies genetic mutations in advanced solid tumors through a blood sample

News comes after the company attained RMAT designation from the FDA for its lung cancer drug

The ctDNA blood draw is known for its ultrasensitive detection capabilities

In mouse experiments using human breast cancer tumors, the results were striking

News of the upcoming debut came the day before World Cancer Day, Feb. 4

Researchers at the International Agency for Research on Cancer examined data from 185 countries to quantify preventable cancer risk